Center for Comparative Medicine, Schools of Medicine and Veterinary Medicine, University of California Davis, Davis, California 95616
Received 2 November 2004/ Returned for modification 22 December 2004/ Accepted 14 January 2005
| ABSTRACT |
|---|
|
|
|---|
| INTRODUCTION |
|---|
|
|
|---|
The ability of B. burgdorferi to survive and adapt to these markedly changing conditions is believed to be facilitated by differential expression of various gene products, particularly outer surface proteins (Osps). A notable example is OspA, a major 31-kDa lipoprotein that is abundantly expressed by B. burgdorferi in the midgut of unfed ticks and by spirochetes grown in artificial media but is generally not expressed during infection of mammalian hosts. OspA has been the subject of intensive investigation since its initial discovery (3, 10, 22, 26, 37, 52). Among the factors that have been shown to modulate OspA expression are temperature (34, 48), pH (51, 52), cocultivation with tick cells (34), exposure to tick hemolymph (20), the presence of anti-OspA antibody within feeding ticks (17), the presence of natural antibody (9), and serum starvation (1).
More germane to the role of OspA in the infectious cycle and the reason for investigating its expression under various conditions is the fact that OspA is highly dynamic in the tick and the host. In unfed infected ticks (nymphs and adults) spirochetes are restricted to their midgut and express abundant OspA (16), whereas feeding by the tick stimulates spirochetes to rapidly multiply and migrate to the salivary glands but significantly down-regulates OspA (13, 14, 47, 48). Immunization of hosts against OspA protects against tick-borne infection by killing OspA-expressing spirochetes in the tick midgut during the initial stages of feeding (22). When spirochetes are transmitted to naïve hosts, they do not express OspA (24, 30, 40) and are therefore no longer vulnerable to OspA immunity (15). These dynamics are reflected in the sera of most patients and animals following tick-borne infection with B. burgdorferi. Such sera do not contain OspA antibody, whereas sera from experimental animals inoculated by syringe with high doses of cultured B. burgdorferi, which expresses OspA, contain OspA antibodies (5, 6, 8, 19, 23, 36, 41, 42).
In contrast to these findings, OspA antibody has been found in the sera of some human patients late in the course of infection, suggesting OspA expression (19, 27, 28). Furthermore, serial serum samples from Lyme disease patients have revealed seroconversion to OspA coinciding with the severity and onset of arthritis, as well as the duration of arthritis (27, 28). The mechanism for this paradoxical event has not been determined, but one possible explanation is that OspA expression can be increased by spirochetes maintained in an inflammatory environment in vivo (12). In addition to OspA antibody in some patients with chronic infections and disease, low levels of OspA antibody, primarily immunoglobulin M (IgM), have been detected in many patients during early infection, but these antibodies tend to be complexed with antigen, and the response appears to be transient (43-45).
In the immunocompetent mouse model of Lyme disease, seroconversion to OspA and ospA transcription have not been detected during infection following tick-borne infection or infection with host-adapted spirochetes (7, 11, 15, 23-25, 42). We recently published seemingly contrary studies that found low levels of ospA mRNA in the skin, hearts, and tibiotarsal joints of C3H-severe combined immunodeficient (C3H-scid) mice inoculated by syringe with cultured B. burgdorferi. Furthermore, ospA mRNA transcription was most commonly found after 2 or more weeks of infection and at sites distant from the inoculation site, suggesting that ospA mRNA transcription took place by disseminating spirochetes within the host (25).
To further explore this phenomenon, we assessed B. burgdorferi ospA mRNA transcription in C3H-scid mice following syringe inoculation, tick-borne inoculation, or inoculation with host-adapted B. burgdorferi and examined the antibody responses in infected C3H-scid mice that were adoptively reconstituted with lymphocytes from immunocompetent mice. The results led to investigation of the effect of non-OspA (nonspecific) antibody on ospA mRNA transcription. Our studies suggest that host innate immunity, mediated through immunoglobulins, is involved in modulation of OspA expression in vivo.
| MATERIALS AND METHODS |
|---|
|
|
|---|
B. burgdorferi. A clonal strain of B. burgdorferi sensu stricto (cN40) was grown in modified Barbour-Stoenner-Kelly (BSK II) medium (2) at 33°C. At the time of necropsy, tissues (blood, inoculation site, and urinary bladder) were cultured in modified BSK II medium, as described previously (6), to confirm the infection status of each mouse.
Mouse inoculation. For syringe inoculation, 104 B. burgdorferi cN40 spirochetes at the mid-log phase in 0.1 ml of BSK II medium were inoculated intradermally at the dorsal thoracic midline into each mouse. For tick-borne inoculation, five nymphal ticks that were infected with B. burgdorferi cN40 were placed on the dorsal thoracic midline and allowed to attach and feed to repletion. For infection with host-adapted spirochetes, 3-mm punches were obtained from ears of infected C3H mice using disposable dermal biopsy punches (Premiere Medical Supply) at 3 weeks after syringe inoculation. The punches were placed in BSK II medium and transplanted beneath the skin of the dorsal thoracic midline through a pocket watch incision, as described previously (4, 7). Recognizing that doses could not be exactly the same with these different types of inocula, we attempted to roughly equilibrate inocula for all of these methods to the 104-spirochete dose inoculated by syringe. For tick inoculation we utilized nymphal ticks with a mean of 5 x 104 spirochetes per tick (unknown numbers were transmitted), and the 3-mm-diameter ear transplants contained a mean of 1.8 x 104 spirochetes, based upon quantitative DNA analysis (see below).
Ticks. I. scapularis ticks were obtained as field-collected adults from southern Connecticut (cordially provided by Durland Fish, Yale University, New Haven, CT), and they produced uninfected larvae for experimental use. All larvae were derived from a single cohort for the experiments described in this study, and a sample of the cohort was confirmed to be uninfected by B. burgdorferi flaB PCR. To generate infected nymphs, larvae were allowed to engorge on C3H mice that had been infected with B. burgdorferi for 2 weeks following syringe inoculation, as described previously (25). A sample of the infected nymphal tick cohort revealed that 97% of the ticks were PCR positive for B. burgdorferi flaB.
Quantitative analysis of B. burgdorferi DNA and mRNA. Tissue samples were weighed, snap-frozen in liquid nitrogen immediately after collection, pulverized, and homogenized, and then they were split equally for use for DNA and RNA extraction. DNA was extracted using DNeasy tissue kits according to the manufacturer's instruction for tissues (QIAGEN, Valencia, CA), and total RNA was purified using RNeasy mini kits according to the manufacturer's instruction for tissues (QIAGEN, Valencia, CA). The copy number of each B. burgdorferi target gene was expressed per mg of tissue. Samples used for RNA analysis were homogenized with a QIAshredder and then treated with RNase-free DNase I prior to elution. The concentration and purity of extracted RNA were determined by measuring the A260 and A280. Extracted total RNA was stored at 80°C until use. For synthesis of cDNA from extracted total RNA, reverse transcription was performed utilizing TaqMan reverse transcription reagents (PE Biosystems, Foster City, CA). cDNA was amplified in a standard heat block instrument after incubation for 10 min at 25°C following transcription at 48°C for 30 min and inactivation at 95°C for 5 min. Real-time PCR was optimized and utilized to quantify B. burgdorferi population dynamics targeting flaB DNA, as well as to evaluate ospA transcriptional activity, targeting ospA cDNA, as described previously (25).
Histology. Hearts and joints (knees, tibiotarsi) were fixed in 10% neutral buffered formalin. Joints were demineralized in decalcifying solution. Formalin-fixed tissues were embedded in paraffin, sectioned at 5 µm, and then stained with hematoxylin using standard histologic techniques.
Serology. An antibody capture enzyme-linked immunosorbent assay (ELISA) was used to determine serum IgM and IgG titers to mouse IgG (heavy and light chains) (Jackson Immuno-Research Laboratories, Inc., West Grove, PA), B. burgdorferi cN40 lysate, and recombinant OspA. Briefly, ELISA plates (Nunc ImmunoMax Maxi-Sorp, Wiesbaden, Germany) were coated with 1 µg/ml of rat anti-mouse IgG (Jackson Immuno-Research Laboratories, Inc.), B. burgdorferi lysate, or recombinant cN40 OspA (21) in carbonate buffer and incubated overnight at 4°C. After the plates were washed and after nonspecific binding was blocked with 1% bovine serum albumin, twofold serial dilutions of sera were titrated in the plates, which were incubated overnight at 4°C. The plates were washed again and then incubated with alkaline phosphatase-conjugated rat-anti mouse IgG(H+L) (Jackson Immuno-Research Laboratories, Inc.). After a final wash, wells were incubated with 1 mg of alkaline phosphatase substrate (Sigma, St. Louis, Mo.) per ml for color development. Absorbance was read with an ELISA reader (Molecular Devices, Sunnyvale, CA) at a test wavelength of 405 nm. Each assay included positive and negative controls for serum. The cutoff point for positive reactions was established at 3 standard deviations above normal mouse serum or control antigen background.
Purification of serum immunoglobulins. Normal mouse serum was obtained from specific-pathogen-free female C3H mice (3 to 5 weeks old). To equilibrate serum to buffer, serum was dialyzed overnight at 4°C against binding buffer (0.1 M sodium phosphate, 0.15 M sodium chloride, pH 7.2). For separation of IgM, the serum was applied to an AminoLink Plus (Pierce Biotechnology, Inc., Rockford, IL) column with immobilized rat anti-mouse IgM antibody. Bound fractions of IgM were eluted with 0.1 M glycine, pH 2.7. For separation of IgG, the remaining serum was applied consecutively to Affinity Pak immobilized protein L (Pierce) and protein G HiTrap affinity (Amersham Biosciences Corporation, Piscataway, NJ) columns. Bound fractions of IgG were eluted with 0.1 M glycine, pH 2.7. The immunoglobulin content of all fractions (normal mouse serum, serum devoid of immunoglobulins, IgG and IgM fractions) was assessed by quantitative ELISA. The concentrations of immunoglobulin in the IgG and IgM fractions were adjusted to the levels detected in the normal mouse serum.
Statistics. Statistical comparisons of mean numbers of spirochetes per mg of tissue for infected C3H-scid and C3H mice were made using StatView (PowerPC version; SAS Institute Inc., Cary, NC). Multiple-comparison analyses were performed with a one-way analysis of variance, followed by a least-difference post hoc test. P values lower than 0.05 were considered significant.
| RESULTS |
|---|
|
|
|---|
At 1 week, hearts from four of five syringe-infected and four of five tick-infected mice, tibiotarsal tissue from four of five syringe-infected and one of five tick-infected mice, and quadriceps muscle from three of five syringe-inoculated mice had detectable flaB DNA (data not shown). At 4 weeks, all mice, regardless of the inoculum, had detectable flaB DNA in all three tissues. In all flaB DNA-positive samples, transcriptional activity of flaB mRNA was detectable. In contrast, ospA mRNA transcription was detected in only one syringe-infected heart sample at 1 week. At 4 weeks, low levels of ospA mRNA transcription were detected in hearts from three of five syringe-infected and two of five tick-infected mice and in tibiotarsi from two of five syringe-infected and three of five tick-infected mice but not in quadriceps muscle (Fig. 1). Collectively, three of five syringe-infected and three of five tick-inoculated mice had detectable ospA mRNA transcription in one or more tissues at 4 weeks. These results confirm previous studies which demonstrated that ospA mRNA transcription occurred during infection of C3H-scid mice (24). The data also suggest that ospA mRNA transcription, albeit low and not detectable in all samples, is more frequent after 4 weeks of infection than after 1 week and therefore likely to reflect up-regulation during infection of the host. Furthermore, the presence of ospA mRNA transcription in inflamed hearts and joints, but not in uninflamed muscle, supports the observation of other workers (12) that inflammation stimulates ospA mRNA transcription.
|
|
Carditis and arthritis were present in the four mice examined at 4 weeks but were not evident in the five mice at 1 week. Although flaB mRNA transcription was present in hearts and joints of all five mice at 1 week, no ospA mRNA transcription was detected at this time. In contrast, ospA mRNA transcription was found in three heart samples and one joint sample at 4 weeks (Fig. 3). These results suggest that host-adapted spirochetes (derived from immunocompetent C3H mice), which do not express OspA, appear to up-regulate ospA mRNA transcription during infection of C3H-scid mice.
|
At necropsy, all mice from both groups (reconstituted and nonreconstituted) were culture and PCR positive. Carditis and arthritis were present in nonreconstituted C3H-scid mice at 4 and 6 weeks, and the arthritis was severe. Inflammatory lesions were present in the heart base but not in the ventricular muscle and were present in the tibiotarsus but not in the quadriceps muscle. Carditis and arthritis were less severe in reconstituted mice at 6 weeks and were regressing at 8 weeks (data not shown). Nonreconstituted C3H-scid mice were examined at 4 weeks to verify transcription of ospA mRNA at a time at which the reconstituted mice would be developing acquired immunity 2 weeks following adoptive transfer. Transcription of ospA mRNA was verified in one or more tissues from four of five mice (two of five heart bases; three of five tibiotarsi) (Fig. 4). Thus, it could be assumed that similarly inoculated but reconstituted C3H-scid mice were likely to immunologically recognize OspA, if it was translated into protein.
|
IgM and IgG were detected in all reconstituted mice at high titers (>1:25,000), confirming that there was successful reconstitution. Antibodies against B. burgdorferi lysates were detected in all reconstituted C3H-scid mice, with the highest titers in mice necropsied at 8 weeks (data not shown). When plates were coated with OspA and probed with sera from reconstituted C3H-scid mice, OspA antibodies were detected at a titer of 1:100 in two of five mice necropsied at 8 weeks (data not shown). Thus, detection of OspA antibodies in reconstituted C3H-scid mice confirmed that the low levels of ospA mRNA transcription in C3H-scid mice are accompanied by OspA translation, based upon seroconversion.
Effect of normal serum on ospA mRNA transcription in infected C3H-scid mice. Other workers (9) have shown that natural antibodies in naïve mice interact with spirochetes in feeding ticks and influence OspA expression within the tick. Therefore, the effect of normal mouse serum on ospA mRNA transcription in infected C3H-scid mice was investigated. Twenty C3H-scid mice were syringe inoculated with B. burgdorferi. Ten of the mice were each injected intraperitoneally with 1 ml of normal (uninfected) C3H mouse serum at the time of inoculation and at 2 weeks, and the other 10 mice received no serum. At 4 weeks, mice were necropsied, tissues were cultured to verify infection, and tissues (heart base, ventricular muscle, tibiotarsus, and quadriceps muscle) were processed for B. burgdorferi DNA and RNA analysis.
All mice were culture positive. The numbers of spirochetes, based upon flaB DNA copy numbers, and the levels of flaB mRNA transcription in each tissue were equivalent in the two groups (serum treated and untreated) of C3H-scid mice (Fig. 5). Transcription of ospA mRNA was found in the heart base of 6 of 10 untreated mice, in the ventricular muscle of 2 of 10 untreated mice, and in the tibiotarsus of 4 of 10 untreated mice. Collectively, 7 of 10 untreated mice had ospA mRNA transcription in one or more tissues. No ospA mRNA transcription was detected in the quadriceps muscle from any of the untreated mice. In contrast, no ospA mRNA transcription was detected in the heart base, ventricular muscle, tibiotarsus, or quadriceps muscle of mice treated with normal mouse serum (10 mice had no ospA mRNA transcription in any tissue). Thus, these results suggest that components of serum from naïve, immunocompetent mice influence ospA mRNA transcription in the host.
|
The various treatments had no effect upon B. burgdorferi flaB DNA levels or flaB mRNA transcription. For the 20 mice and 20 tissue samples from each mouse, ospA mRNA transcription was found only in tissues from three mice (two of three heart base samples, one of three tibiotarsus samples) treated with serum that was depleted of immunoglobulin (Fig. 6). Furthermore, these results confirmed the effect of normal mouse serum and nonspecific immunoglobulins on ospA mRNA transcription.
|
| DISCUSSION |
|---|
|
|
|---|
In other studies of B. burgdorferi infection of C3H-scid mice workers have not observed ospA mRNA transcription. Liang et al. (31) were unable to detect ospA mRNA transcription in C3H-scid mice using less sensitive microarray approaches. Crother et al. (11) were not able to detect OspA protein in detergent-phase tissue extracts from C3H-scid mice infected for 17 days with B. burgdorferi B31, but other proteins, including VlsE, OspC, and DbpA, were detectable. The inability to detect OspA was possibly due to the very small amounts of OspA in tissues, which the present data suggest, and possibly also due to the early time (17 days). Real-time PCR is a highly sensitive and quantitative means for detecting RNA transcripts in tissues of mice infected with B. burgdorferi, and it has recently been utilized to demonstrate dynamics of gene expression during infection in both immunocompetent and immunodeficient mice (24, 25, 32). Acquired immunity by the host has been shown to significantly reduce, but not eliminate, spirochetes from tissues, with commensurate reduction of transcription of several genes, including flaB, ospC, dbpA, arp (BBF01), vlsE, fbp (BBK32), oppA-2, and p37-42 (BBK47). The only absolute reduction in gene transcription in all tissues under these circumstances was the reduction in ospA transcription (24). These results were confirmed in a recent study that examined dbpA, ospC, BBF01, and vlsE mRNA transcription, but that study involved fewer tissues and ospA mRNA transcription was not examined (32).
It has been generally accepted that B. burgdorferi, which expresses abundant amounts of OspA in unfed ticks, rapidly down-regulates ospA mRNA transcription during tick feeding upon a host (16, 33, 48). The signals for this profound change in surface protein expression are not known, but a recent study has shown that natural antibody in nonimmune mice is a significant factor (9). Ninety percent of spirochetes in the salivary glands of ticks feeding upon B-cell-deficient mice were shown to express OspA, in contrast to only 5% of spirochetes from ticks feeding upon naïve, immunocompetent mice. Furthermore, the spirochete numbers in the midguts of ticks were significantly reduced in ticks feeding upon immunocompetent mice compared to B-cell-deficient mice. Passive transfer of normal mouse serum into the B-cell-deficient mice was sufficient to induce these profound shifts in OspA expression. It has been known for some time that natural IgM interacts with OspA on spirochetes grown in vitro (18, 50). Furthermore, sera from several different species of animals, which were not exposed to B. burgdorferi, have been shown to contain natural antibodies that can kill spirochetes in vitro in the presence of complement (29). Although we did not observe reductions in spirochete numbers in infected C3H-scid mice that were passively treated with normal mouse serum, our results complement these other studies by demonstrating the role of natural antibodies as a signal for ospA mRNA transcription modulation in vivo and maintenance of ospA down-regulation during persistent infection of the host.
The down-regulation of ospA mRNA transcription during tick feeding is not absolute, as some spirochetes in the salivary glands of feeding ticks have been shown to express OspA (35, 46-48). In a recent study examining B. burgdorferi population kinetics and gene expression at the host-vector interface, it was shown that spirochetes which initially enter the host at the site of tick feeding transiently transcribe ospA mRNA at 24 h but rapidly down-regulate ospA mRNA transcription by 48 h and beyond in immunocompetent C3H mice (25). The current study confirmed this observation, using C3H-scid mice. Thus, transient OspA expression explains the finding of early antibody responses to OspA, which tend to rapidly decline in both experimental animals and humans (43, 45). Studies of C3H-scid mice infected with cultured (24), host-adapted, or tick-borne spirochetes (current study) indicate that ospA mRNA transcription continues in the host in the absence of immune competence, and the critical signaling factor is natural immunoglobulin.
Because of the relative paucity of spirochetes in tissues and the relatively low level of ospA mRNA transcription in infected mice, we attempted to prove OspA translation and expression indirectly with an adoptive transfer experiment. The results demonstrated that there was seroconversion of infected C3H-scid mice that were reconstituted with normal lymphocytes from naïve, immunocompetent C3H mice. However, seroconversion to OspA took place in only two of five mice that were successfully reconstituted. All five mice readily seroconverted to B. burgdorferi. The variable results are likely due to the fact that ospA mRNA transcription was down-regulated during the early phases of reconstitution because of sensitivity to natural immunoglobulin, thereby reducing or eliminating the antigenic stimulus at a time when full immunocompetence was affected. Nevertheless, we established the fact that some of the mice seroconverted specifically to OspA, thereby proving that OspA translation occurred in vivo.
The regulatory effector for ospA transcription in vivo, at least in part, is immunoglobulin. Our study compartmentalized the effector to either IgM or IgG. Nonspecific immunoglobulins, possibly natural antibody, have been shown to significantly influence OspA expression in the tick. In the previous study, as in the current study, the IgM and IgG fractions of normal mouse serum were tested, but only IgM was found to be effective at modifying OspA expression in ticks. It was speculated that the lack of effect of IgG on OspA expression in ticks may have been due to IgG binding proteins in tick saliva (9). It remains to be determined if the effects of immunoglobulins on ospA mRNA transcription and OspA expression are actually due to natural antibodies that are specifically reactive with OspA or due to some other mechanism. If specificity is required, this finding may provide insight into why OspA may be expressed in some Lyme disease patients who seroconvert to OspA during the late stages of infection.
| ACKNOWLEDGMENTS |
|---|
| FOOTNOTES |
|---|
| REFERENCES |
|---|
|
|
|---|
| 1. | Alban, P. S., P. W. Johnson, and D. R. Nelson. 2000. Serum-starvation-induced changes in protein synthesis and morphology of Borrelia burgdorferi. Microbiology 146:119-127. |
| 2. | Anderson, J. F., and L. A. Magnarelli. 1993. Epizootiology of Lyme disease-causing borreliae. Clin. Dermatol. 11:339-351[CrossRef][Medline] |
| 3. | Barbour, A. G., S. L. Tessier, and W. J. Todd. 1983. Lyme disease spirochetes and ixodid tick spirochetes share a common surface antigenic determinant defined by a monoclonal antibody. Infect Immun. 41:795-804. |
| 4. | Barthold, S. W. 1993. Antigenic stability of Borrelia burgdorferi during chronic infections of immunocompetent mice. Infect. Immun. 61:4955-4961. |
| 5. | Barthold, S. W., and L. K. Bockenstedt. 1993. Passive immunizing activity of sera from mice infected with Borrelia burgdorferi. Infect. Immun. 61:4696-4702. |
| 6. | Barthold, S. W., M. S. de Souza, J. L. Janotka, A. L. Smith, and D. H. Persing. 1993. Chronic Lyme borreliosis in the laboratory mouse. Am. J. Pathol. 143:959-971.[Abstract] |
| 7. | Barthold, S. W., E. Fikrig, L. K. Bockenstedt, and D. H. Persing. 1995. Circumvention of outer surface protein A immunity by host-adapted Borrelia burgdorferi. Infect. Immun. 63:2255-2261.[Abstract] |
| 8. | Barthold, S. W., S. A. Levy, E. Fikrig, L. K. Bockenstedt, and A. L. Smith. 1995. Serologic responses of dogs naturally exposed to or vaccinated against Borrelia burgdorferi infection. J. Am. Vet. Med. Assoc. 207:1435-1440.[Medline] |
| 9. | Belperron, A. A., and L. K. Bockenstedt. 2001. Natural antibody affects survival of the spirochete Borrelia burgdorferi within feeding ticks. Infect. Immun. 69:6456-6462. |
| 10. | Bergstrom, S., V. G. Bundoc, and A. G. Barbour. 1989. Molecular analysis of linear plasmid-encoded major surface proteins, OspA and OspB, of the Lyme disease spirochaete Borrelia burgdorferi. Mol. Microbiol. 3:479-486.[CrossRef][Medline] |
| 11. | Crother, T. R., C. I. Champion, X. Y. Wu, D. R. Blanco, J. N. Miller, and M. A. Lovett. 2003. Antigenic composition of Borrelia burgdorferi during infection of SCID mice. Infect. Immun. 71:3419-3428. |
| 12. | Crowley, H., and B. T. Huber. 2003. Host-adapted Borrelia burgdorferi in mice expresses OspA during inflammation. Infect. Immun. 71:4003-4010. |
| 13. | de Silva, A. M., and E. Fikrig. 1997. Arthropod- and host-specific gene expression by Borrelia burgdorferi. J. Clin. Investig. 99:377-379.[Medline] |
| 14. | De Silva, A. M., and E. Fikrig. 1997. Borrelia burgdorferi genes selectively expressed in ticks and mammals. Parasitol. Today 13:267-270.[CrossRef][Medline] |
| 15. | de Silva, A. M., E. Fikrig, E. Hodzic, F. S. Kantor, S. R. Telford III, and S. W. Barthold. 1998. Immune evasion by tickborne and host-adapted Borrelia burgdorferi. J. Infect. Dis. 177:395-400.[Medline] |
| 16. | de Silva, A. M., S. R. Telford III, L. R. Brunet, S. W. Barthold, and E. Fikrig. 1996. Borrelia burgdorferi OspA is an arthropod-specific transmission-blocking Lyme disease vaccine. J. Exp. Med. 183:271-275. |
| 17. | de Silva, A. M., N. S. Zeidner, Y. Zhang, M. C. Dolan, J. Piesman, and E. Fikrig. 1999. Influence of outer surface protein A antibody on Borrelia burgdorferi within feeding ticks. Infect. Immun. 67:30-35. |
| 18. | Dorward, D. W., E. D. Huguenel, G. Davis, and C. F. Garon. 1992. Interactions between extracellular Borrelia burgdorferi proteins and non-Borrelia-directed immunoglobulin M antibodies. Infect. Immun. 60:838-844. |
| 19. | Dressler, F., J. A. Whalen, B. N. Reinhardt, and A. C. Steere. 1993. Western blotting in the serodiagnosis of Lyme disease. J. Infect. Dis. 167:392-400.[Medline] |
| 20. | Ewing, C., A. Scorpio, D. R. Nelson, and T. N. Mather. 1994. Isolation of Borrelia burgdorferi from saliva of the tick vector, Ixodes scapularis. J. Clin. Microbiol. 32:755-758. |
| 21. | Feng, S., E. Hodzic, K. Freet, and S. W. Barthold. 2003. Immunogenicity of Borrelia burgdorferi arthritis-related protein. Infect. Immun. 71:7211-7214. |
| 22. | Fikrig, E., S. R. Telford III, S. W. Barthold, F. S. Kantor, A. Spielman, and R. A. Flavell. 1992. Elimination of Borrelia burgdorferi from vector ticks feeding on OspA-immunized mice. Proc. Natl. Acad. Sci. USA 89:5418-5421. |
| 23. | Gern, L., U. E. Schaible, and M. M. Simon. 1993. Mode of inoculation of the Lyme disease agent Borrelia burgdorferi influences infection and immune responses in inbred strains of mice. J. Infect. Dis. 167:971-975.[Medline] |
| 24. | Hodzic, E., S. Feng, K. J. Freet, and S. W. Barthold. 2003. Borrelia burgdorferi population dynamics and prototype gene expression during infection of immunocompetent and immunodeficient mice. Infect. Immun. 71:5042-5055. |
| 25. | Hodzic, E., S. Feng, K. J. Freet, D. L. Borjesson, and S. W. Barthold. 2002. Borrelia burgdorferi population kinetics and selected gene expression at the host-vector interface. Infect. Immun. 70:3382-3388. |
| 26. | Howe, T. R., L. W. Mayer, and A. G. Barbour. 1985. A single recombinant plasmid expressing two major outer surface proteins of the Lyme disease spirochete. Science 227:645-646. |
| 27. | Kalish, R. A., J. M. Leong, and A. C. Steere. 1993. Association of treatment-resistant chronic Lyme arthritis with HLA-DR4 and antibody reactivity to OspA and OspB of Borrelia burgdorferi. Infect. Immun. 61:2774-2779. |
| 28. | Kalish, R. A., J. M. Leong, and A. C. Steere. 1995. Early and late antibody responses to full-length and truncated constructs of outer surface protein A of Borrelia burgdorferi in Lyme disease. Infect. Immun. 63:2228-2235.[Abstract] |
| 29. | Kurtenbach, K., H. S. Sewell, N. H. Ogden, S. E. Randolph, and P. A. Nuttall. 1998. Serum complement sensitivity as a key factor in Lyme disease ecology. Infect. Immun. 66:1248-1251. |
| 30. | Leuba-Garcia, S., R. Martinez, and L. Gern. 1998. Expression of outer surface proteins A and C of Borrelia afzelii in Ixodes ricinus ticks and in the skin of mice. Zentralbl. Bakteriol. 287:475-484.[Medline] |
| 31. | Liang, F. T., F. K. Nelson, and E. Fikrig. 2002. DNA microarray assessment of putative Borrelia burgdorferi lipoprotein genes. Infect. Immun. 70:3300-3303. |
| 32. | Liang, F. T., J. Yan, M. L. Mbow, S. L. Sviat, R. D. Gilmore, M. Mamula, and E. Fikrig. 2004. Borrelia burgdorferi changes its surface antigenic expression in response to host immune responses. Infect. Immun. 72:5759-5767. |
| 33. | Montgomery, R. R., S. E. Malawista, K. J. Feen, and L. K. Bockenstedt. 1996. Direct demonstration of antigenic substitution of Borrelia burgdorferi ex vivo: exploration of the paradox of the early immune response to outer surface proteins A and C in Lyme disease. J. Exp. Med. 183:261-269. |
| 34. | Obonyo, M., U. G. Munderloh, V. Fingerle, B. Wilske, and T. J. Kurtti. 1999. Borrelia burgdorferi in tick cell culture modulates expression of outer surface proteins A and C in response to temperature. J. Clin. Microbiol. 37:2137-2141. |
| 35. | Ohnishi, J., J. Piesman, and A. M. de Silva. 2001. Antigenic and genetic heterogeneity of Borrelia burgdorferi populations transmitted by ticks. Proc. Natl. Acad. Sci. USA 98:670-675. |
| 36. | Pachner, A. R., D. Dail, L. Li, L. Gurey, S. Feng, E. Hodzic, and S. Barthold. 2002. Humoral immune response associated with Lyme borreliosis in nonhuman primates: analysis by immunoblotting and enzyme-linked immunosorbent assay with sonicates or recombinant proteins. Clin. Diagn. Lab. Immunol. 9:1348-1355. |
| 37. | Pal, U., A. M. de Silva, R. R. Montgomery, D. Fish, J. Anguita, J. F. Anderson, Y. Lobet, and E. Fikrig. 2000. Attachment of Borrelia burgdorferi within Ixodes scapularis mediated by outer surface protein A. J. Clin. Investig. 106:561-569.[Medline] |
| 38. | Peavey, C. A., and R. S. Lane. 1995. Transmission of Borrelia burgdorferi by Ixodes pacificus nymphs and reservoir competence of deer mice (Peromyscus maniculatus) infected by tick-bite. J. Parasitol. 81:175-178.[CrossRef][Medline] |
| 39. | Piesman, J. 1993. Dynamics of Borrelia burgdorferi transmission by nymphal Ixodes dammini ticks. J. Infect. Dis. 167:1082-1085.[Medline] |
| 40. | Porcella, S. F., and T. G. Schwan. 2001. Borrelia burgdorferi and Treponema pallidum: a comparison of functional genomics, environmental adaptations, and pathogenic mechanisms. J. Clin. Investig. 107:651-656.[Medline] |
| 41. | Roehrig, J. T., J. Piesman, A. R. Hunt, M. G. Keen, C. M. Happ, and B. J. Johnson. 1992. The hamster immune response to tick-transmitted Borrelia burgdorferi differs from the response to needle-inoculated, cultured organisms. J. Immunol. 149:3648-3653.[Abstract] |
| 42. | Schaible, U. E., L. Gern, R. Wallich, M. D. Kramer, M. Prester, and M. M. Simon. 1993. Distinct patterns of protective antibodies are generated against Borrelia burgdorferi in mice experimentally inoculated with high and low doses of antigen. Immunol. Lett. 36:219-226.[CrossRef][Medline] |
| 43. | Schutzer, S. E., P. K. Coyle, J. J. Dunn, B. J. Luft, and M. Brunner. 1994. Early and specific antibody response to OspA in Lyme disease. J. Clin. Investig. 94:454-457. |
| 44. | Schutzer, S. E., P. K. Coyle, L. B. Krupp, Z. Deng, A. L. Belman, R. Dattwyler, and B. J. Luft. 1997. Simultaneous expression of Borrelia OspA and OspC and IgM response in cerebrospinal fluid in early neurologic Lyme disease. J. Clin. Investig. 100:763-767.[Medline] |
| 45. | Schutzer, S. E., and J. Luan. 2003. Early OspA immune complex formation in animal models of Lyme disease. J. Mol. Microbiol. Biotechnol. 5:167-171.[CrossRef][Medline] |
| 46. | Schwan, T. G., R. H. Karstens, M. E. Schrumpf, and W. J. Simpson. 1991. Changes in antigenic reactivity of Borrelia burgdorferi, the Lyme disease spirochete, during persistent infection in mice. Can. J. Microbiol. 37:450-454.[Medline] |
| 47. | Schwan, T. G., and J. Piesman. 2000. Temporal changes in outer surface proteins A and C of the Lyme disease-associated spirochete, Borrelia burgdorferi, during the chain of infection in ticks and mice. J. Clin. Microbiol. 38:382-388. |
| 48. | Schwan, T. G., J. Piesman, W. T. Golde, M. C. Dolan, and P. A. Rosa. 1995. Induction of an outer surface protein on Borrelia burgdorferi during tick feeding. Proc. Natl. Acad. Sci. USA 92:2909-2913. |
| 49. | Spielman, A., J. F. Levine, and M. L. Wilson. 1984. Vectorial capacity of North American Ixodes ticks. Yale J. Biol. Med. 57:507-513.[Medline] |
| 50. | Whitmire, W. M., and C. F. Garon. 1993. Specific and nonspecific responses of murine B cells to membrane blebs of Borrelia burgdorferi. Infect. Immun. 61:1460-1467. |
| 51. | Yang, X., T. G. Popova, K. E. Hagman, S. K. Wikel, G. B. Schoeler, M. J. Caimano, J. D. Radolf, and M. V. Norgard. 1999. Identification, characterization, and expression of three new members of the Borrelia burgdorferi Mlp (2.9) lipoprotein gene family. Infect. Immun. 67:6008-6018. |
| 52. | Yang, X. F., U. Pal, S. M. Alani, E. Fikrig, and M. V. Norgard. 2004. Essential role for OspA/B in the life cycle of the Lyme disease spirochete. J. Exp. Med. 199:641-648. |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|